123 related articles for article (PubMed ID: 3786490)
1. Separation of the tremorous and muscular rigidity components of the ethanol withdrawal syndrome in the rat.
Derr RF; Derr MI
Physiol Behav; 1986; 38(1):1-3. PubMed ID: 3786490
[TBL] [Abstract][Full Text] [Related]
2. Suppression by gamma-hydroxybutyric acid of ethanol withdrawal syndrome in rats.
Fadda F; Colombo G; Mosca E; Gessa GL
Alcohol Alcohol; 1989; 24(5):447-51. PubMed ID: 2818752
[TBL] [Abstract][Full Text] [Related]
3. A comparison of calcium antagonists and diazepam in reducing ethanol withdrawal tremors.
Bone GH; Majchrowicz E; Martin PR; Linnoila M; Nutt DJ
Psychopharmacology (Berl); 1989; 99(3):386-8. PubMed ID: 2594904
[TBL] [Abstract][Full Text] [Related]
4. Suppression of an ethanol withdrawal syndrome in rats by butyrate, lactate and beta-hydroxybutyrate.
Derr RF; Draves K; Derr M
Life Sci; 1983 May; 32(22):2551-4. PubMed ID: 6682922
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of ethanol withdrawal syndrome by extract of Hypericum perforatum in Wistar rats.
Coskun I; Tayfun Uzbay I; Ozturk N; Ozturk Y
Fundam Clin Pharmacol; 2006 Oct; 20(5):481-8. PubMed ID: 16968419
[TBL] [Abstract][Full Text] [Related]
6. Suppression by progabide of ethanol withdrawal syndrome in rats.
Fadda F; Mosca E; Meloni R; Gessa GL
Eur J Pharmacol; 1985 Mar; 109(3):321-5. PubMed ID: 2985405
[TBL] [Abstract][Full Text] [Related]
7. Suppression of an ethanol withdrawal syndrome in rats by 3-hydroxybutyrate.
Derr RF; Derr M
Life Sci; 1985 Feb; 36(8):763-7. PubMed ID: 4038774
[TBL] [Abstract][Full Text] [Related]
8. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.
Gallimberti L; Canton G; Gentile N; Ferri M; Cibin M; Ferrara SD; Fadda F; Gessa GL
Lancet; 1989 Sep; 2(8666):787-9. PubMed ID: 2571021
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity studies of neurotensin on muscular rigidity and tremors induced by 6-hydroxydopamine lesions in the posterolateral hypothalamus of the rat.
Rivest R; St-Pierre S; Jolicoeur FB
Neuropharmacology; 1991 Jan; 30(1):47-52. PubMed ID: 1904561
[TBL] [Abstract][Full Text] [Related]
10. Ethanol withdrawal tremor does not interact with physostigmine-induced tremor in rat.
Gothoni P
Pharmacol Biochem Behav; 1985 Sep; 23(3):339-44. PubMed ID: 4048228
[TBL] [Abstract][Full Text] [Related]
11. The ethanol withdrawal syndrome: a consequence of lack of substrate for a cerebral Krebs-cycle.
Derr RF
J Theor Biol; 1984 Feb; 106(3):375-81. PubMed ID: 6371387
[TBL] [Abstract][Full Text] [Related]
12. Differential sensitivity of ethanol withdrawal signs in the rat to gamma-aminobutyric acid (GABA)mimetics: blockade of audiogenic seizures but not forelimb tremors.
Frye GD; McCown TJ; Breese GR
J Pharmacol Exp Ther; 1983 Sep; 226(3):720-5. PubMed ID: 6310080
[TBL] [Abstract][Full Text] [Related]
13. Harmine-, LON-954- and 5-hydroxytryptophan-induced tremors in rats withdrawn from ethanol.
Gothóni P
Acta Pharmacol Toxicol (Copenh); 1985 Jul; 57(1):40-6. PubMed ID: 3876687
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of the antialcohol effect of gamma-hydroxybutyric acid.
Gessa GL; Agabio R; Carai MA; Lobina C; Pani M; Reali R; Colombo G
Alcohol; 2000 Apr; 20(3):271-6. PubMed ID: 10869869
[TBL] [Abstract][Full Text] [Related]
15. Effects of dexmedetomidine on rat locus coeruleus and ethanol withdrawal symptoms during intermittent ethanol exposure.
Riihioja P; Jaatinen P; Haapalinna A; Kiianmaa K; Hervonen A
Alcohol Clin Exp Res; 1999 Mar; 23(3):432-8. PubMed ID: 10195815
[TBL] [Abstract][Full Text] [Related]
16. Physiological action tremor: a basis for understanding alcohol withdrawal tremor.
Burgstahler SA; Wittmers LE; Petry RW; Pozos RS
Curr Alcohol; 1981; 8():79-84. PubMed ID: 7343196
[TBL] [Abstract][Full Text] [Related]
17. Quantification of rigidity and tremor activity in rats by using a new device and its validation by different classes of drugs.
Nickel B; Kolasiewicz W; Szelenyi I
Arzneimittelforschung; 1997 Oct; 47(10):1081-6. PubMed ID: 9368698
[TBL] [Abstract][Full Text] [Related]
18. Acute and chronic tianeptine treatments attenuate ethanol withdrawal syndrome in rats.
Uzbay T; Kayir H; Celik T; Yüksel N
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):478-85. PubMed ID: 16412550
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of ethanol withdrawal signs by high doses of L-arginine in rats.
Uzbay IT; Erden BF
Alcohol Alcohol; 2003; 38(3):213-8. PubMed ID: 12711654
[TBL] [Abstract][Full Text] [Related]
20. Electroencephalographic and behavioral correlates in rats during repeated ethanol withdrawal syndromes.
Poldrugo F; Snead OC
Psychopharmacology (Berl); 1984; 83(2):140-6. PubMed ID: 6431463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
